GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM9046
Query DataSets for GSM9046
Status
Public on Feb 29, 2004
Title
nc3
Sample type
RNA
Source name
adipose tissue
Organism
Homo sapiens
Extracted molecule
total RNA
Description
Total RNA was extracted from umbilical subcutaneous adipose tissue from an individual affected with FCHL and exhibiting the USF1 protective haplotype
Submission date
Aug 13, 2003
Last update date
May 28, 2005
Contact name
Massimiliano Gentile
E-mail(s)
[email protected]
Phone
+358-9-47448726
URL
http://www.bioinfo.helsinki.fi
Organization name
Biomedicum Helsinki
Department
Biomedicum Bioinformatics Unit
Lab
Biomedicum Bioinformatics Unit
Street address
Haartmaninkatu 8
City
Helsinki
ZIP/Postal code
000 14
Country
Finland
Platform ID
GPL96
Series (1)
GSE590
USF1 haplotype comparison
Data table header descriptions
ID_REF
VALUE
signal intensity
ABS_CALL
quality flag: absent, marginal or present
DETECTION P-VALUE
p-value on flag
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
65.4
P
0.030976
AFFX-BioB-M_at
117.3
P
0.00039
AFFX-BioB-3_at
75.9
P
0.000662
AFFX-BioC-5_at
219.5
P
0.000446
AFFX-BioC-3_at
162.5
P
0.000195
AFFX-BioDn-5_at
255.2
P
0.000052
AFFX-BioDn-3_at
1356.4
P
0.000147
AFFX-CreX-5_at
2245.7
P
0.000044
AFFX-CreX-3_at
3103.9
P
0.000044
AFFX-DapX-5_at
9.1
A
0.250796
AFFX-DapX-M_at
8.8
A
0.574038
AFFX-DapX-3_at
1.9
A
0.945787
AFFX-LysX-5_at
3.5
A
0.645547
AFFX-LysX-M_at
2.8
A
0.699409
AFFX-LysX-3_at
1.4
A
0.783476
AFFX-PheX-5_at
1.6
A
0.891021
AFFX-PheX-M_at
1.3
A
0.966323
AFFX-PheX-3_at
9.8
A
0.60308
AFFX-ThrX-5_at
1.5
A
0.971543
AFFX-ThrX-M_at
7.6
A
0.52976
Total number of rows:
22283
Table truncated, full table size
579 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|